Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Chemotherapy in the elderly].

G Lümmen1, H Rübben

  • 1Urologische Klinik und Poliklinik, Universitätsklinik, Essen. gerd.luemmen@uni-esssen

Der Urologe. Ausg. A
|November 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Treatment mapping of lower urinary tract symptoms due to benign prostatic hyperplasia-an analysis of the Governing Body of German Prostate Centers].

Der Urologe. Ausg. A·2020
Same author

Correction to: The natural course of pT2 prostate cancer with positive surgical margin: predicting biochemical recurrence.

World journal of urology·2020
Same author

[Urinary bladder cancer as a late sequela of spinal cord injury : Decision-making aids for assessment of this causal association].

Der Urologe. Ausg. A·2020
Same author

[Erratum to: How should urologists perform implantation of subcutaneous central venous port systems? A single center experience of 347 cases].

Der Urologe. Ausg. A·2018
Same author

[Incontinence].

Der Urologe. Ausg. A·2017
Same author

[When is surgical treatment indicated in metastatic urothelial carcinoma and what is the scientific rationale?]

Der Urologe. Ausg. A·2017
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
Same journal

Der Urologe. Ausg. A·2022
See all related articles

Cancer incidence rises with age, but age is not a barrier to chemotherapy. Careful assessment of elderly patients' health and functional status is crucial for safe and effective cancer treatment.

Area of Science:

  • Oncology
  • Geriatric Medicine
  • Pharmacology

Context:

  • Cancer incidence increases with age.
  • Physiological changes in the elderly impact drug metabolism.
  • Elderly populations are underrepresented in clinical trials.

Purpose:

  • To evaluate the role of chemotherapy in elderly cancer patients.
  • To highlight the need for dose adjustments in geriatric chemotherapy.
  • To address the lack of data on chemotherapy outcomes in older adults.

Summary:

  • Chemotherapy is viable for elderly cancer patients, provided comorbidities and functional status are assessed.
  • Age-related declines in renal function and hepatic metabolism necessitate chemotherapy dose adaptation.
  • Anticipated treatment response and toxicity in the elderly are comparable to younger patients, despite limited trial data.

Related Experiment Videos

Impact:

  • Provides guidance for oncologists treating elderly cancer patients.
  • Emphasizes personalized chemotherapy dosing for geriatric populations.
  • Highlights the need for increased inclusion of elderly individuals in clinical research.